Found: 72
Select item for more details and to access through your institution.
A novel plasma p-tau181 assay as a specific biomarker of tau pathology in Alzheimer's disease.
- Published in:
- Translational Neurodegeneration, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40035-024-00439-4
- By:
- Publication type:
- Article
A new method to quantify tau pathologies with C-PBB3 PET using reference tissue voxels extracted from brain cortical gray matter.
- Published in:
- EJNMMI Research, 2016, v. 6, n. 1, p. 1, doi. 10.1186/s13550-016-0182-y
- By:
- Publication type:
- Article
Brain 5-HT<sub>2A</sub> receptor binding and its neural network related to behavioral inhibition system.
- Published in:
- Brain Imaging & Behavior, 2022, v. 16, n. 3, p. 1337, doi. 10.1007/s11682-021-00609-2
- By:
- Publication type:
- Article
Distinct binding of amyloid imaging ligands to unique amyloid-β deposited in the presubiculum of Alzheimer's disease.
- Published in:
- Journal of Neurochemistry, 2015, v. 135, n. 5, p. 859, doi. 10.1111/jnc.13293
- By:
- Publication type:
- Article
Effect of tracer metabolism on PET measurement of [11C]pyrilamine binding to histamine H1 receptors.
- Published in:
- 1999
- By:
- Publication type:
- journal article
Application of a beta microprobe for quantification of regional cerebral blood flow with (15)O-water and PET in rhesus monkeys.
- Published in:
- 1998
- By:
- Publication type:
- journal article
Noncompartmental and compartmental modeling of the kinetics of carbon-11 labeled pyrilamine in the human brain.
- Published in:
- Synapse, 1993, v. 15, n. 4, p. 263, doi. 10.1002/syn.890150403
- By:
- Publication type:
- Article
Quantitative Analysis of Peripheral Benzodiazepine Receptor in the Human Brain Using PET with <sup>11</sup>C-AC-5216.
- Published in:
- Journal of Nuclear Medicine, 2009, v. 50, n. 7, p. 1095, doi. 10.2967/jnumed.109.062554
- By:
- Publication type:
- Article
Quantitative PET Analysis of the Dopamine D<sub>2</sub> Receptor Agonist Radioligand <sup>11</sup>C-(R)-2-CH<sub>3</sub>O-N-n-Propylnorapomorphine in the Human Brain.
- Published in:
- Journal of Nuclear Medicine, 2009, v. 50, n. 5, p. 703, doi. 10.2967/jnumed.108.058503
- By:
- Publication type:
- Article
Quantitative Analysis of NK<sub>1</sub> Receptor in the Human Brain Using PET with <sup>18</sup>F-FE-SPA-RQ.
- Published in:
- Journal of Nuclear Medicine, 2008, v. 49, n. 11, p. 1749, doi. 10.2967/jnumed.108.054353
- By:
- Publication type:
- Article
Quantitative Analysis of Norepinephrine Transporter in the Human Brain Using PET with (S,S)-<sup>18</sup>F-FMeNER-D<sub>2</sub>.
- Published in:
- Journal of Nuclear Medicine, 2008, v. 49, n. 8, p. 1270, doi. 10.2967/jnumed.108.051292
- By:
- Publication type:
- Article
Changes in effective diffusivity for oxygen during neural activation and deactivation estimated from capillary diameter measured by two-photon laser microscope.
- Published in:
- Journal of Physiological Sciences, 2017, v. 67, n. 2, p. 325, doi. 10.1007/s12576-016-0466-z
- By:
- Publication type:
- Article
Multimodal Imaging for DREADD-Expressing Neurons in Living Brain and Their Application to Implantation of iPSC-Derived Neural Progenitors.
- Published in:
- Journal of Neuroscience, 2016, v. 36, n. 45, p. 11544, doi. 10.1523/JNEUROSCI.1279-16.2016
- By:
- Publication type:
- Article
Grouping tau topologies in former boxers assessed by PET with <sup>18</sup>F‐PM‐PBB3: A reappraisal of dementia pugilistica: Neuroimaging / Optimal neuroimaging measures for tracking disease progression.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.041510
- By:
- Publication type:
- Article
Activation of Nav1.1 ameliorates tau pathology and brain atrophy in a mouse model of tauopathy: Nonhuman/Target identification and validation studies: Tau.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.038201
- By:
- Publication type:
- Article
P4‐586: CLINICAL CHARACTERIZATION OF [<sup>18</sup>F]PM‐PBB3 IN THE BRAINS OF MILD‐REPETITIVE TRAUMATIC BRAIN INJURY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P1546, doi. 10.1016/j.jalz.2019.08.134
- By:
- Publication type:
- Article
P2‐382: IN VIVO TRACKING OF TAU PATHOLOGIES WITH <sup>18</sup>F‐PM‐PBB3 (<sup>18</sup>F‐APN‐1607) PET IN AD AND DIVERSE NON‐AD TAUOPATHIES.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P749, doi. 10.1016/j.jalz.2019.06.2789
- By:
- Publication type:
- Article
IC‐P‐179: IN VIVO TRACKING OF TAU PATHOLOGIES WITH <sup>18</sup>F‐PM‐PBB3 (<sup>18</sup>F‐APN‐1607) PET IN AD AND DIVERSE NON‐AD TAUOPATHIES.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P140, doi. 10.1016/j.jalz.2019.06.4294
- By:
- Publication type:
- Article
IC‐P‐179: IN VIVO TRACKING OF TAU PATHOLOGIES WITH <sup>18</sup>F‐PM‐PBB3 (<sup>18</sup>F‐APN‐1607) PET IN AD AND DIVERSE NON‐AD TAUOPATHIES.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P140, doi. 10.1016/j.jalz.2019.06.4294
- By:
- Publication type:
- Article
P1‐125: PRECLINICAL AND CLINICAL CHARACTERIZATION OF <sup>18</sup>F‐PM‐PBB3, A PET LIGAND FOR DIVERSE TAU PATHOLOGIES.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P318, doi. 10.1016/j.jalz.2018.06.128
- By:
- Publication type:
- Article
IC‐P‐217: PRECLINICAL AND CLINICAL CHARACTERIZATION OF <sup>18</sup>F‐PM‐PBB3, A PET LIGAND FOR DIVERSE TAU PATHOLOGIES.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P177, doi. 10.1016/j.jalz.2018.06.2284
- By:
- Publication type:
- Article
FIRST-IN-HUMAN PET STUDY WITH 18F-AM-PBB3 AND 18F-PM-PBB3.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P146, doi. 10.1016/j.jalz.2017.06.2573
- By:
- Publication type:
- Article
FIRST-IN-HUMAN PET STUDY WITH 18F-AM-PBB3 AND 18F-PM-PBB3.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P1104, doi. 10.1016/j.jalz.2017.06.1594
- By:
- Publication type:
- Article
Prediction of the Clinical SUV Ratio in Amyloid PET Imaging Using a Biomathematic Modeling Approach Toward the Efficient Development of a Radioligand.
- Published in:
- Journal of Nuclear Medicine, 2017, v. 58, n. 8, p. 1285, doi. 10.2967/jnumed.116.183566
- By:
- Publication type:
- Article
PET Quantification of the Norepinephrine Transporter in Human Brain with (S,S)-<sup>18</sup>F-FMeNER-D<sub>2</sub>.
- Published in:
- Journal of Nuclear Medicine, 2017, v. 58, n. 7, p. 1140, doi. 10.2967/jnumed.116.178913
- By:
- Publication type:
- Article
PET Quantification of Tau Pathology in Human Brain with <sup>11</sup>C-PBB3.
- Published in:
- Journal of Nuclear Medicine, 2015, v. 56, n. 9, p. 1359, doi. 10.2967/jnumed.115.160127
- By:
- Publication type:
- Article
Quantitative Analysis of Amyloid Deposition in Alzheimer Disease Using PET and the Radiotracer <sup>11</sup>C-AZD2184.
- Published in:
- Journal of Nuclear Medicine, 2014, v. 55, n. 6, p. 932, doi. 10.2967/jnumed.113.133793
- By:
- Publication type:
- Article
Quantification of Dopamine Transporter in Human Brain Using PET with <sup>18</sup>F-FE-PE2I.
- Published in:
- Journal of Nuclear Medicine, 2012, v. 53, n. 7, p. 1065, doi. 10.2967/jnumed.111.101626
- By:
- Publication type:
- Article
Association of protein distribution and gene expression revealed by positron emission tomography and postmortem gene expression in the dopaminergic system of the human brain.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 13, p. 3928, doi. 10.1007/s00259-023-06390-2
- By:
- Publication type:
- Article
Binding of Dopamine D<sub>1</sub> Receptor and Noradrenaline Transporter in Individuals with Autism Spectrum Disorder: A PET Study.
- Published in:
- Cerebral Cortex, 2020, v. 30, n. 12, p. 6458, doi. 10.1093/cercor/bhaa211
- By:
- Publication type:
- Article
Quantification of monoacylglycerol lipase and its occupancy by an exogenous ligand in rhesus monkey brains using [ 18 F]T-401 and PET.
- Published in:
- Journal of Cerebral Blood Flow & Metabolism, 2022, v. 42, n. 4, p. 656, doi. 10.1177/0271678X211058285
- By:
- Publication type:
- Article
Dynamic alterations in the central glutamatergic status following food and glucose intake: in vivo multimodal assessments in humans and animal models.
- Published in:
- Journal of Cerebral Blood Flow & Metabolism, 2021, v. 41, n. 11, p. 2928, doi. 10.1177/0271678X211004150
- By:
- Publication type:
- Article
PET imaging of colony-stimulating factor 1 receptor: A head-to-head comparison of a novel radioligand, 11 C-GW2580, and 11 C-CPPC, in mouse models of acute and chronic neuroinflammation and a rhesus monkey.
- Published in:
- Journal of Cerebral Blood Flow & Metabolism, 2021, v. 41, n. 9, p. 2410, doi. 10.1177/0271678X211004146
- By:
- Publication type:
- Article
Detection of Alzheimer's disease-related neuroinflammation by a PET ligand selective for glial versus vascular translocator protein.
- Published in:
- Journal of Cerebral Blood Flow & Metabolism, 2021, v. 41, n. 8, p. 2076, doi. 10.1177/0271678X21992457
- By:
- Publication type:
- Article
Positron emission tomography of cerebral angiogenesis and TSPO expression in a mouse model of chronic hypoxia.
- Published in:
- Journal of Cerebral Blood Flow & Metabolism, 2018, v. 38, n. 4, p. 687, doi. 10.1177/0271678X16689800
- By:
- Publication type:
- Article
Synthesis and evaluation of a novel PET ligand, a GSK'963 analog, aiming at autoradiography and imaging of the receptor interacting protein kinase 1 in the brain.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2023, v. 8, n. 1, p. 1, doi. 10.1186/s41181-023-00217-z
- By:
- Publication type:
- Article
Synthesis and evaluation of a novel PET ligand, a GSK'963 analog, aiming at autoradiography and imaging of the receptor interacting protein kinase 1 in the brain.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2023, v. 8, n. 1, p. 1, doi. 10.1186/s41181-023-00217-z
- By:
- Publication type:
- Article
Selective Disruption of Inhibitory Synapses Leading to Neuronal Hyperexcitability at an Early Stage of Tau Pathogenesis in a Mouse Model.
- Published in:
- Journal of Neuroscience, 2020, v. 40, n. 17, p. 3491, doi. 10.1523/JNEUROSCI.2880-19.2020
- By:
- Publication type:
- Article
In vivo PET classification of tau pathologies in patients with frontotemporal dementia.
- Published in:
- Brain Communications, 2024, v. 6, n. 2, p. 1, doi. 10.1093/braincomms/fcae075
- By:
- Publication type:
- Article
Positron Emission Tomography Assessments of Phosphodiesterase 10A in Patients With Schizophrenia.
- Published in:
- Schizophrenia Bulletin, 2023, v. 49, n. 3, p. 688, doi. 10.1093/schbul/sbac181
- By:
- Publication type:
- Article
A quantitative in vivo imaging platform for tracking pathological tau depositions and resultant neuronal death in a mouse model.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 13, p. 4298, doi. 10.1007/s00259-022-05898-3
- By:
- Publication type:
- Article
Correction to: First‑in‑human in vivo imaging and quantification of monoacylglycerol lipase in the brain: a PET study with <sup>18</sup>F‑T‑401.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 9, p. 3299, doi. 10.1007/s00259-022-05795-9
- By:
- Publication type:
- Article
First-in-human in vivo imaging and quantification of monoacylglycerol lipase in the brain: a PET study with <sup>18</sup>F-T-401.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 9, p. 3150, doi. 10.1007/s00259-021-05671-y
- By:
- Publication type:
- Article
Pharmacokinetic and pharmacodynamic assessment of histamine H<sub>3</sub> receptor occupancy by enerisant: a human PET study with a novel H<sub>3</sub> binding ligand, [<sup>11</sup>C]TASP457.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 4, p. 1127, doi. 10.1007/s00259-021-05571-1
- By:
- Publication type:
- Article
Synthesis and preclinical evaluation of [<sup>11</sup>C]MTP38 as a novel PET ligand for phosphodiesterase 7 in the brain.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 10, p. 3101, doi. 10.1007/s00259-021-05269-4
- By:
- Publication type:
- Article
A first-in-human study of 11C-MTP38, a novel PET ligand for phosphodiesterase 7.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 9, p. 2846, doi. 10.1007/s00259-021-05235-0
- By:
- Publication type:
- Article
[C]TASP457, a novel PET ligand for histamine H receptors in human brain.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2016, v. 43, n. 9, p. 1653, doi. 10.1007/s00259-016-3332-6
- By:
- Publication type:
- Article
Wavelet denoising for voxel-based compartmental analysis of peripheral benzodiazepine receptors with <sup>18</sup>F-FEDAA1106.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2008, v. 35, n. 2, p. 416, doi. 10.1007/s00259-007-0623-y
- By:
- Publication type:
- Article
Increased glutamate and glutamine levels and their relationship to astrocytes and dopaminergic transmissions in the brains of adults with autism.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-38306-3
- By:
- Publication type:
- Article
Histamine H<sub>3</sub> receptor density is negatively correlated with neural activity related to working memory in humans.
- Published in:
- EJNMMI Research, 2018, v. 8, n. 1, p. 1, doi. 10.1186/s13550-018-0406-4
- By:
- Publication type:
- Article